GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. in the Healthcare sector is trading at $67.71 with a market capitalization of $2.6B. Wall Street consensus targets $93.50 (8 analysts), implying a +38.1% move over the next 12 months. The stock is currently 60% below its 52-week high of $170.87, remaining 10.5% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 23 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.